Provided by Tiger Fintech (Singapore) Pte. Ltd.

NLS Pharmaceutics Ltd.

1.47
+0.04002.80%
Post-market: 1.490.0200+1.36%18:58 EDT
Volume:47.44K
Turnover:70.64K
Market Cap:1.72M
PE:-0.22
High:1.53
Open:1.44
Low:1.44
Close:1.43
Loading ...
Nov 04, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 27, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Jun 25, 2024

Correspondence

Form CORRESP - Correspondence
May 30, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
May 16, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 27, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
May 05, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 24, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 18, 2023

Correspondence

CORRESP [Cover] - Correspondence
Jan 03, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 13, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 17, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jun 10, 2022

Public Prospectus

F-1 - Registration statement for certain foreign private issuers
Mar 24, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]